文献速递美容整形

A型肉毒毒素减少鼻翼活动度的单盲前瞻性研究

A Single-Blinded Prospective Study on Using Botulinum Toxin Type A for Reducing Alar Mobility.
PubMed 文献 · Aesthet Surg J · 2022-01-01

本研究为单盲前瞻性研究,纳入20名希望改善鼻翼动态美学的参与者,实验组在四个鼻翼扩张肌注射3U A型肉毒毒素,对照组注射等量生理盐水。三维成像显示实验组鼻翼外扩活动度从10.05%±6.40%降至4.91%±3.48%(P<0.05),鼻翼基底活动度从16.83%±5.69%降至12.50%±4.89%(P<0.05),对照组无显著变化。结论认为A型肉毒毒素可有效抑制鼻翼活动度且无显著不良事件。

要点

  • 鼻翼扩张肌注射3U A型肉毒毒素可显著降低鼻翼外扩和基底活动度。
  • 三维成像结合均方根分析可用于客观评估鼻翼动态美学改善。
  • 该方法可作为鼻整形的微创辅助治疗,无显著不良事件。

核心结论

  • A型肉毒毒素能有效抑制鼻翼活动度,改善鼻翼动态美学,可作为鼻整形的微创方法或辅助治疗。

研究设计与样本

  • 单盲前瞻性研究,纳入20名希望改善鼻翼动态美学的参与者,实验组注射3U A型肉毒毒素,对照组注射等量生理盐水。

主要发现

  • 实验组鼻翼外扩活动度从10.05%±6.40%降至4.91%±3.48%(P<0.05)。
  • 实验组鼻翼基底活动度从16.83%±5.69%降至12.50%±4.89%(P<0.05)。
  • 对照组鼻翼活动度无显著变化。
  • 均方根分析显示实验组变化显著高于对照组(P<0.05)。

关键数值与推荐

  • 注射部位为鼻翼前扩张肌、鼻翼前庭扩张肌、提上唇鼻翼肌和鼻翼扩张肌,每点3U A型肉毒毒素。
  • 鼻翼活动度计算公式为MOBILITY=(微笑时宽度-静息时宽度)/静息时宽度×100%。

临床怎么用

  • 对于希望改善鼻翼动态美学或作为鼻整形辅助的患者,可考虑鼻翼扩张肌群注射3U A型肉毒毒素。
  • 使用三维成像系统标准化记录从静息到最大微笑(不露齿)的面部运动以评估疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With widespread utilization of instant social media, people desire a minimally invasive treatment to improve alar dynamic aesthetic, but few practical procedures on reducing alar mobility have been conducted. OBJECTIVES: This study aimed to verify the effects of botulinum toxin on reducing nasal alar mobility and provide a supplemental treatment of rhinoplasty. METHODS: This single-blind prospective study included a cohort of 20 participants with the desire to improve their alar dynamic aesthetic. The experimental group was injected with 3U botulinum toxin type A at dilator naris anterior, dilator naris vestibularis, levator labii superioris alaeque nasi, and dilator naris, and the control group received the equivalent of saline. Standardized facial movement (from rest to maximum smile without revealing teeth) was recorded with a 3-dimensional imaging system. The changes between rest and maximum smile statuses represented alar mobility and were generated by MOBILITY=WIDTHsmile-WIDTHrestWIDTHrest×100 % . Alar mobility and root mean square analysis were employed for postoperative evaluations. RESULTS: In the experimental group, alar flaring mobility decreased from 10.05% ± 6.40% to 4.91% ± 3.48%(P < 0.05), and alar base mobility decreased from 16.83% ± 5.69% to 12.50% ± 4.89% (P < 0.05), whereas no significant changes in alar mobility were found in the control group. In root mean square analysis, changes in the experimental group were significantly higher than in the control group (P < 0.05). CONCLUSIONS: Botulinum toxin type A can effectively restrain alar mobility without any significant adverse events and improve alar dynamic esthetic, which can serve as a minimally invasive method or supplemental treatment for rhinoplasty.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Zhong Y, Cao D, Zhou S, et al. A Single-Blinded Prospective Study on Using Botulinum Toxin Type A for Reducing Alar Mobility. Aesthet Surg J. 2022. PMID: 34533193. doi:10.1093/asj/sjab343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。